These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17110431)

  • 1. Suppression of androgen receptor transactivation and prostate cancer cell growth by heterogeneous nuclear ribonucleoprotein A1 via interaction with androgen receptor coregulator ARA54.
    Yang Z; Chang YJ; Miyamoto H; Yeh S; Yao JL; di Sant'Agnese PA; Tsai MY; Chang C
    Endocrinology; 2007 Mar; 148(3):1340-9. PubMed ID: 17110431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgelin functions as a suppressor via inhibition of ARA54-enhanced androgen receptor transactivation and prostate cancer cell growth.
    Yang Z; Chang YJ; Miyamoto H; Ni J; Niu Y; Chen Z; Chen YL; Yao JL; di Sant'Agnese PA; Chang C
    Mol Endocrinol; 2007 Feb; 21(2):343-58. PubMed ID: 17082327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dominant-negative mutant of androgen receptor coregulator ARA54 inhibits androgen receptor-mediated prostate cancer growth.
    Miyamoto H; Rahman M; Takatera H; Kang HY; Yeh S; Chang HC; Nishimura K; Fujimoto N; Chang C
    J Biol Chem; 2002 Feb; 277(7):4609-17. PubMed ID: 11673464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen-receptor coregulators mediate the suppressive effect of androgen signals on vitamin D receptor activity.
    Ting HJ; Bao BY; Hsu CL; Lee YF
    Endocrine; 2005 Feb; 26(1):1-9. PubMed ID: 15805579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen receptor (AR) NH2- and COOH-terminal interactions result in the differential influences on the AR-mediated transactivation and cell growth.
    Hsu CL; Chen YL; Ting HJ; Lin WJ; Yang Z; Zhang Y; Wang L; Wu CT; Chang HC; Yeh S; Pimplikar SW; Chang C
    Mol Endocrinol; 2005 Feb; 19(2):350-61. PubMed ID: 15514032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and characterization of human prostate coactivator ARA54, a novel protein that associates with the androgen receptor.
    Kang HY; Yeh S; Fujimoto N; Chang C
    J Biol Chem; 1999 Mar; 274(13):8570-6. PubMed ID: 10085091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of androgen receptor N-terminal and ligand binding domain interacting coregulators in prostate cancer.
    Yeh S; Sampson ER; Lee DK; Kim E; Hsu CL; Chen YL; Chang HC; Altuwaijri S; Huang KE; Chang C
    J Formos Med Assoc; 2000 Dec; 99(12):885-94. PubMed ID: 11155740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of androgen receptor associated coregulators in prostate cancer cells.
    Sampson ER; Yeh SY; Chang HC; Tsai MY; Wang X; Ting HJ; Chang C
    J Biol Regul Homeost Agents; 2001; 15(2):123-9. PubMed ID: 11501969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative modulation of androgen receptor transcriptional activity by Daxx.
    Lin DY; Fang HI; Ma AH; Huang YS; Pu YS; Jenster G; Kung HJ; Shih HM
    Mol Cell Biol; 2004 Dec; 24(24):10529-41. PubMed ID: 15572661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteasome activity is required for androgen receptor transcriptional activity via regulation of androgen receptor nuclear translocation and interaction with coregulators in prostate cancer cells.
    Lin HK; Altuwaijri S; Lin WJ; Kan PY; Collins LL; Chang C
    J Biol Chem; 2002 Sep; 277(39):36570-6. PubMed ID: 12119296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells.
    Esmaeili M; Jennek S; Ludwig S; Klitzsch A; Kraft F; Melle C; Baniahmad A
    J Mol Cell Biol; 2016 Jun; 8(3):207-20. PubMed ID: 26993046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer: prognostic significance of the association of heterogeneous nuclear ribonucleoprotein K and androgen receptor expression.
    Barboro P; Salvi S; Rubagotti A; Boccardo S; Spina B; Truini M; Carmignani G; Introini C; Ferrari N; Boccardo F; Balbi C
    Int J Oncol; 2014 May; 44(5):1589-98. PubMed ID: 24626777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TR2 orphan receptor functions as negative modulator for androgen receptor in prostate cancer cells PC-3.
    Mu X; Chang C
    Prostate; 2003 Oct; 57(2):129-33. PubMed ID: 12949936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro gene expression changes of androgen receptor coactivators after hormone deprivation in an androgen-dependent prostate cancer cell line.
    Chang HC; Chen SC; Chen J; Hsieh JT
    J Formos Med Assoc; 2005 Sep; 104(9):652-8. PubMed ID: 16276440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CR6-interacting factor 1 represses the transactivation of androgen receptor by direct interaction.
    Suh JH; Shong M; Choi HS; Lee K
    Mol Endocrinol; 2008 Jan; 22(1):33-46. PubMed ID: 17885209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen receptor activity is affected by both nuclear matrix localization and the phosphorylation status of the heterogeneous nuclear ribonucleoprotein K in anti-androgen-treated LNCaP cells.
    Barboro P; Borzì L; Repaci E; Ferrari N; Balbi C
    PLoS One; 2013; 8(11):e79212. PubMed ID: 24236111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional domain and motif analyses of androgen receptor coregulator ARA70 and its differential expression in prostate cancer.
    Hu YC; Yeh S; Yeh SD; Sampson ER; Huang J; Li P; Hsu CL; Ting HJ; Lin HK; Wang L; Kim E; Ni J; Chang C
    J Biol Chem; 2004 Aug; 279(32):33438-46. PubMed ID: 15166229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneous nuclear ribonucleoprotein K is a novel regulator of androgen receptor translation.
    Mukhopadhyay NK; Kim J; Cinar B; Ramachandran A; Hager MH; Di Vizio D; Adam RM; Rubin MA; Raychaudhuri P; De Benedetti A; Freeman MR
    Cancer Res; 2009 Mar; 69(6):2210-8. PubMed ID: 19258514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation.
    Chen SY; Cai C; Fisher CJ; Zheng Z; Omwancha J; Hsieh CL; Shemshedini L
    Oncogene; 2006 Nov; 25(54):7212-23. PubMed ID: 16732317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel crosstalk between the tumor suppressors ING1 and ING2 regulates androgen receptor signaling.
    Esmaeili M; Pungsrinont T; Schaefer A; Baniahmad A
    J Mol Med (Berl); 2016 Oct; 94(10):1167-1179. PubMed ID: 27305909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.